Cash, Debt and the DividendNarrow moat

Philip Morris International (PM) — moat facet

PMI runs negative equity and $43 billion of net debt on a business that spends less than 4% of revenue on capital, and pays a rising dividend on top.

PMI's financial structure is the result of its moat: a business that needs little capital can carry a lot of debt and pay a large dividend. Operating cash flow was $12,233 million in 2025 against capital expenditure of $1,569 million1, and PMI paid $8,624 million of dividends2. It carried net debt of $43,963 million3 and a stockholders' deficit of $9,994 million4 at the end of the year.

Uses of cash, 2025 ($M)12,233Operating cash flow8,624Dividends paid1,569Capital expenditurePMI Form 10-K FY2025
Most of the cash goes to the dividend.

The structure works because the cash flow is reliable. Net debt fell to 2.35 times adjusted EBITDA by June 20265, from 2.66 times at the end of 20246, and PMI expects to reach close to 2.0 times by the end of 20267. The dividend has risen every year since 20088.

Return on invested capital, the right measure for a company with negative equity, was 32.5% in 2025 on our calculation9. That is lower than the 49% to 57% of 2018 to 202110, because the Swedish Match purchase added about $16.8 billion to the capital base11, but still four times an 8% hurdle.

The structure also constrains. There is no room for buybacks until the leverage target is met12, and there is no equity cushion for a large write-down. PMI's history includes both: a $2,316 million Canadian impairment in 202413 and a $665 million wellness goodwill write-down in 202314.

The market prices the whole structure accordingly. PMI's enterprise value, market value plus net debt and other claims, was $340.02 billion in September 2026, 18.87 times EBITDA15, a multiple more usual for a steady consumer brand than for a leveraged tobacco company.

This aspect is narrow and stable. The ratio of net debt to adjusted EBITDA is the measure; 2.35 times at 30 June 202616, and a reading above 2.5 at the end of 2026 would say the cash flow is no longer outrunning the debt.

Moat trajectory: Holding steady

Leverage falling; no buybacks until about 2.0x.

The number that tests this moat
Reported
Net debt to adjusted EBITDA, latest quarter
2.35x (30 June 2026), from 2.53x

Whether cash flow is outrunning the debt; above 2.5x at end-2026 would mean it is not.

Source: PMI Q2 2026 non-GAAP schedules ↗
Aspects of the moat
DIG DEEPER 01
A Dividend Raised Every Year Since 2008
PMI has raised its dividend every year since 2008, to $6.40 a share, and the 2026-2028 plan leaves no room for buybacks beside it.
DIG DEEPER 02
Net Debt Down to 2.35 Times
PMI has cut its leverage from 2.66 to 2.35 times EBITDA without cutting its debt, by growing into it.
DIG DEEPER 03
Twelve Billion Dollars of Operating Cash
PMI turns about $12 billion a year of operating cash into about $10.7 billion of free cash, because its factories cost less than 4% of revenue.
DIG DEEPER 04
Negative Equity: Why Return on Equity Means Nothing Here
PMI's equity is below zero because it has paid out more than it kept, so its return on invested capital, not equity, is the number that matters.
⚠ Threats to the moat
⚠ THREAT 01
The Wellness Write-Offs
PMI spent more than $2.2 billion on Vectura and Fertin Pharma in 2021 and has since written down or sold most of it at a loss.
⚠ THREAT 02
A New Finance Chief Mid-Deleveraging
PMI replaced its CFO in August 2026, just as the balance sheet reaches the point where capital-allocation choices reopen.
References
  1. ReportedOperating cash flow was $12,233 million in 2025 against capital expenditure of $1,569 million, and PMI paid $8,624 million of dividends.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  2. ReportedOperating cash flow was $12,233 million in 2025 against capital expenditure of $1,569 million, and PMI paid $8,624 million of dividends.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  3. ReportedIt carried net debt of $43,963 million and a stockholders' deficit of $9,994 million at the end of the year.
    Philip Morris International Q4 2025 exhibit 99.2 - total debt, net debt, adjusted EBITDA and net debt to adjusted EBITDA. — FY2025 · publ. 6 February 2026 · source ↗
  4. ReportedIt carried net debt of $43,963 million and a stockholders' deficit of $9,994 million at the end of the year.
    Philip Morris International Form 10-K for fiscal 2025 - financial statements and notes: income statement, excise, cash flow, debt, acquisitions and impairments. — FY2025 · publ. 6 February 2026 · source ↗
  5. ReportedNet debt fell to 2.35 times adjusted EBITDA by June 2026, from 2.66 times at the end of 2024, and PMI expects to reach close to 2.0 times by the end of 2026.
    Philip Morris International Q2 2026 exhibit 99.2 - non-GAAP schedules, operating cash flow and net debt to adjusted EBITDA. — Q2 2026 · publ. 22 July 2026 · source ↗
  6. ReportedNet debt fell to 2.35 times adjusted EBITDA by June 2026, from 2.66 times at the end of 2024, and PMI expects to reach close to 2.0 times by the end of 2026.
    Philip Morris International Q4 2025 exhibit 99.2 - total debt, net debt, adjusted EBITDA and net debt to adjusted EBITDA. — FY2025 · publ. 6 February 2026 · source ↗
  7. ReportedNet debt fell to 2.35 times adjusted EBITDA by June 2026, from 2.66 times at the end of 2024, and PMI expects to reach close to 2.0 times by the end of 2026.
    Philip Morris International second-quarter 2026 results release, Form 8-K exhibit 99.1 - volumes, shares, ZYN and 2026 guidance - results, margins, operating companies income, cash and 2026 guidance. — Q2 2026 · publ. 22 July 2026 · source ↗
  8. ReportedThe dividend has risen every year since 2008.
    Philip Morris International dividend increase release, 18 September 2026. — September 2026 · publ. 18 September 2026 · source ↗
  9. Moat Explorer calcReturn on invested capital, the right measure for a company with negative equity, was 32.5% in 2025 on our calculation.
    Moat Explorer calculation, tools_roic_edgar.py method on SEC EDGAR XBRL for CIK 1413329: return on invested capital 45.6% (2015), 50.2% (2016), 43.4% (2017), 50.7% (2018), 48.7% (2019), 52.1% (2020), 57.2% (2021), 40.6% (2022), 26.8% (2023), 28.6% (2024), 32.5% (2025). — 2015-2025 · publ. September 2026 · source ↗
    Method: NOPAT (operating income x (1 - effective tax rate)) divided by average operating invested capital (total assets less current liabilities less cash), from SEC EDGAR XBRL with the tools_roic_edgar.py method. The 2022 step down reflects the Swedish Match acquisition entering invested capital. Return on equity is not meaningful because PMI has a stockholders' deficit.
  10. Moat Explorer calcThat is lower than the 49% to 57% of 2018 to 2021, because the Swedish Match purchase added about $16.8 billion to the capital base, but still four times an 8% hurdle.
    Moat Explorer calculation, tools_roic_edgar.py method on SEC EDGAR XBRL for CIK 1413329: return on invested capital 45.6% (2015), 50.2% (2016), 43.4% (2017), 50.7% (2018), 48.7% (2019), 52.1% (2020), 57.2% (2021), 40.6% (2022), 26.8% (2023), 28.6% (2024), 32.5% (2025). — 2015-2025 · publ. September 2026 · source ↗
    Method: NOPAT (operating income x (1 - effective tax rate)) divided by average operating invested capital (total assets less current liabilities less cash), from SEC EDGAR XBRL with the tools_roic_edgar.py method. The 2022 step down reflects the Swedish Match acquisition entering invested capital. Return on equity is not meaningful because PMI has a stockholders' deficit.
  11. Moat Explorer calcThat is lower than the 49% to 57% of 2018 to 2021, because the Swedish Match purchase added about $16.8 billion to the capital base, but still four times an 8% hurdle.
    Moat Explorer calculation from Philip Morris International's reported figures ($ millions unless stated). Excise and revenue 2025: 53,211 / 40,648 = 1.31 dollars of excise per dollar of net revenue; gross of excise 53,211 + 40,648 = 93,859, excise share 53,211 / 93,859 = 56.7%; excise growth 2023-2025 53,211 / 49,404 - 1 = 7.7% against net revenue growth 40,648 / 35,174 - 1 = 15.6%. Product mix 2025: smoke-free 16,854 / 40,648 = 41.5%; combustible 23,794 / 40,648 = 58.5%; smoke-free 2023 12,840 / 35,174 = 36.5%, 2024 14,660 / 37,878 = 38.7%; smoke-free growth 2023-2025 16,854 / 12,840 - 1 = 31.3%; smoke-free revenue 2016 733 to 2025 16,854 = 23 times. Segments 2025: International Smoke-Free 13,996 / 40,648 = 34.4%; International Combustibles 23,436 / 40,648 = 57.7%; U.S. 3,216 / 40,648 = 7.9%; recast gross profit shares 9,576 / 27,304 = 35.1%, 15,523 / 27,304 = 56.9%, 2,206 / 27,304 = 8.1%. Growth 2025: ISF 13,996 / 12,126 - 1 = 15.4%; IC 23,436 / 22,807 - 1 = 2.8%; U.S. 3,216 / 2,944 - 1 = 9.2%. Growth 2024: ISF 12,126 / 11,102 - 1 = 9.2%; IC 22,807 / 21,903 - 1 = 4.1%; U.S. 2,944 / 2,169 - 1 = 35.7%. IC gross profit 15,523 / 13,972 - 1 = 11.1% against IC revenue 23,436 / 21,903 - 1 = 7.0% (2023-2025). Recast reported gross margins 2023: ISF 7,021 / 11,102 = 63.2%, IC 13,972 / 21,903 = 63.8%; 2024: ISF 7,831 / 12,126 = 64.6%, IC 14,687 / 22,807 = 64.4%. Segment sum 2024 12,126 + 22,807 + 2,944 = 37,877 against 37,878 reported. IC shares of net revenues 21,903 / 35,174 = 62.3% (2023), 22,807 / 37,878 = 60.2% (2024). U.S. revenue 3,216 / 2,169 - 1 = 48.3% (2023-2025). Q2 2026 shares: ISF 3,877 / 11,192 = 34.6%, IC 6,459 / 11,192 = 57.7%, U.S. 856 / 11,192 = 7.6%. U.S. gross margin Q2 2026 555 / 856 = 64.8% against 611 / 862 = 70.9%. Swedish Match: 14,460 + 1,495 + 883 = 16,838 total cash paid; U.S. adjusted operating companies income 1,124 / 16,838 = 6.7% pre-tax; reported U.S. OCI 322 / 3,216 = 10.0% of U.S. revenue; adjusted 1,124 / 3,216 = 35.0%. Goodwill and other intangibles 17,264 + 10,884 = 28,148, 28,148 / 69,185 = 40.7% of total assets. Volumes: cigarettes 607,367 / 616,827 - 1 = -1.5% (2025), 607,367 / 612,949 - 1 = -0.9% (2023-2025); heated tobacco units 155,133 / 139,743 - 1 = 11.0% (2025), 139,743 / 125,263 - 1 = 11.6% (2024); HTUs 155,133 / (607,367 + 155,133) = 20.3% of cigarette plus HTU shipments. U.S. ZYN cans 793.7 / 384.8 = 2.06 times (2023-2025), 793.7 / 580.5 - 1 = 36.7% (2025); international nicotine pouches 879.6 - 793.7 = 85.9 million cans (2025), 644.0 - 580.5 = 63.5 (2024); snus 227.9 / 240.4 - 1 = -5.2% (2023-2025); e-vapor 3,330 / 1,651 = 2.0 times. U.S. segment: cigars 358 / 410 - 1 = -12.7%, 358 / 431 - 1 = -16.9% (2023-2025); wellness 238 / 333 - 1 = -28.5%. Cash and dividends: free cash flow 12,233 - 1,569 = 10,664 (2025), 12,217 - 1,444 = 10,773 (2024), 9,204 - 1,321 = 7,883 (2023); dividends paid / free cash flow 8,624 / 10,664 = 80.9% (2025), 8,197 / 10,773 = 76.1% (2024), 7,964 / 7,883 = 101.0% (2023). Payout of declared dividends per share over diluted EPS: 5.64 / 7.26 = 77.7% (2025), 5.30 / 4.52 = 117.3% (2024), 5.14 / 5.02 = 102.4% (2023); over adjusted EPS 5.64 / 7.54 = 74.8%. Annualised dividend 1.60 x 4 = 6.40; 6.40 / 5.64 = 1.13; dividend 5.64 / 1.54 = 3.7 times since 2008; yield 6.40 / 190.48 = 3.4%. R&D 756 / 40,648 = 1.9% of revenue; capex 1,569 / 40,648 = 3.9%. Customers: two customers 12% + 10% = 22% of 2025 net revenues; related-party revenue 4,582 / 40,648 = 11.3%; Megapolis 2,805 / 40,648 = 6.9%; Megapolis growth 2,805 / 2,393 - 1 = 17.2%. Japan 4.2 / 40.6 = 10.3% of net revenues. Canada: RBH carrying value 3,280 fair value at deconsolidation to 51 at 30 June 2026; impairments 2,316 + 511 = 2,827. Valuation: trailing twelve months to June 2026 revenue 40,648 + 21,338 - 19,441 = 42,545; net earnings 11,348 + 5,255 - 5,729 = 10,874; P/E 296.88 / 10.874 = 27.3; P/S 296.88 / 42.545 = 6.98; 2018 P/E 103.78 / 7.911 = 13.1; 2025 P/E 249.68 / 11.348 = 22.0; free cash flow yield 10,664 / 296,880 = 3.6%. Other PMI cigarette brands: 25.4 - 9.8 = 15.6% (2023), 25.3 - 10.7 = 14.6% (2025), a loss of 1.0 point against Marlboro's gain of 0.9. Excise Q2 2026 14,973 / 13,272 - 1 = 12.8% against net revenues 11,192 / 10,140 - 1 = 10.4%. U.S. smoke-free H1 1,584 - 1,311 = 273 decline. ISF H1 2026 gross margin 5,400 / 7,713 = 70.0%. Gross margin 2025 27,282 / 40,648 = 67.1%. ROIC average 2015-2025 (45.6 + 50.2 + 43.4 + 50.7 + 48.7 + 52.1 + 57.2 + 40.6 + 26.8 + 28.6 + 32.5) / 11 = 43.3%. Employees 84,900 - 82,700 = 2,200 (2023-2025); net revenues 40,648 - 35,174 = 5,474, about 5.5 billion. Snus 240.4 - 227.9 = 12.5 million cans. Europe smoke-free 8,127 / 16,854 = 48.2%, about half. Cigarette decline 2% to 3% of 607,367 = 12,147 to 18,221 million units. Operating cash flow over R&D 12,233 / 756 = 16.2 times. Blocked markets 440 / 2,587 = 17%, about a sixth. Market cap against peers 296.88 / 119.41 = 2.5 times British American Tobacco; 296.88 / 114.91 = 2.6 times Altria. Net debt to adjusted EBITDA 43,963 / 17,375 = 2.53. Interest 966 / 14,892 = 6.5% of operating income. Guidance midpoints: (8.35 + 8.50) / 2 = 8.43, reported (7.28 + 7.43) / 2 = 7.36, gap 8.43 - 7.36 = 1.07; earlier adjusted midpoints (8.38 + 8.53) / 2 = 8.46, (8.31 + 8.46) / 2 = 8.39, (8.26 + 8.41) / 2 = 8.34; 8.43 / 7.54 - 1 = 11.8% - growth rates, volumes, margins and excise. — 2015-2026 · publ. September 2026 · source ↗
    Method: Arithmetic on figures reported in PMI's Forms 10-K and 10-Q, the recast segment schedules, results releases and market data; operands shown in the source line.
  12. ReportedThere is no room for buybacks until the leverage target is met, and there is no equity cushion for a large write-down.
    Philip Morris International second-quarter 2026 results release, Form 8-K exhibit 99.1 - volumes, shares, ZYN and 2026 guidance - results, margins, operating companies income, cash and 2026 guidance. — Q2 2026 · publ. 22 July 2026 · source ↗
  13. ReportedPMI's history includes both: a $2,316 million Canadian impairment in 2024 and a $665 million wellness goodwill write-down in 2023.
    Philip Morris International Form 10-K for fiscal 2025 - Item 1A risk factors and legal proceedings: excise, Germany, Russia, Canada and credit. — FY2025 · publ. 6 February 2026 · source ↗
  14. ReportedPMI's history includes both: a $2,316 million Canadian impairment in 2024 and a $665 million wellness goodwill write-down in 2023.
    Philip Morris International Form 10-K for fiscal 2023 - the six-segment view with Swedish Match and Wellness and Healthcare, and the $665 million Wellness and Healthcare goodwill impairment. — FY2023 · publ. February 2024 · source ↗
  15. ReportedPMI's enterprise value, market value plus net debt and other claims, was $340.02 billion in September 2026, 18.87 times EBITDA, a multiple more usual for a steady consumer brand than for a leveraged tobacco company.
    Philip Morris International (PM) statistics - trailing P/E 27.41, forward P/E 21.65, P/S 6.98, negative book value, return on equity not meaningful, enterprise value $340.02B, EV/EBITDA 18.87, 52-week change +16.86%. — September 2026 · publ. 25 September 2026 · source ↗
  16. ReportedThe ratio of net debt to adjusted EBITDA is the measure; 2.35 times at 30 June 2026, and a reading above 2.5 at the end of 2026 would say the cash flow is no longer outrunning the debt.
    Philip Morris International Q2 2026 exhibit 99.2 - non-GAAP schedules, operating cash flow and net debt to adjusted EBITDA. — Q2 2026 · publ. 22 July 2026 · source ↗
Sources
Generated September 26, 2026